Category:Hormones and Cancer Therapy
From Glioblastoma Treatments
Hormones and Cancer Therapy
This category includes hormones and hormone-related therapies that may influence cancer progression and treatment outcomes. These include both natural hormones and drugs that affect hormonal pathways.
Drug Name | Overall Survival without PBT | Overall Survival with PBT | Progression-Free Survival without PBT | Progression-Free Survival with PBT | Usefulness Rating | toxicity level | Toxicity Explanation | |
---|---|---|---|---|---|---|---|---|
Angiotensin-Il Receptor Blockers (ARB) | Angiotensin-Il Receptor Blockers (ARB) | Not specified | Not specified | Not specified | Not specified | Not rated | Not specified | Not specified |
Beta-blockers (especially propranolol) and the role of the sympathetic | Beta-blockers (especially propranolol) and the role of the sympathetic | Not specified | Not specified | Not specified | Not specified | Not rated | Not specified | Not specified |
Melatonin | Melatonin | 1 out of 16 patients was alive after one year. | 6 out of 14 patients were alive after one year | Not specified | Not specified | 4 | 1 | Melatonin is considered to have a low toxicity level, with no known toxic side effects. It is generally regarded as safe for use in the dosages typically administered for both sleep disorders and experimental cancer treatment protocols. |
Thyroid Hormone T4 (Thyroxine) Suppression | Thyroid Hormone T4 (Thyroxine) Suppression | Not specified | Not specified | Not specifically documented; focus on overall survival improvements | 3 | 2 | The toxicity level of Thyroid Hormone T4 Suppression Therapy is rated as a 2, which indicates a low level of toxicity. This is because the therapy is designed to suppress the hormone levels in the body and replace them with a synthetic version to help fight cancer cells. The side effects, such as fatigue, are typically manageable, especially when the treatment is carefully monitored. Nonetheless, this therapy is not without potential side effects and it is applied off-label, hence it's necessary to discuss with your healthcare provider. | |
Vitamin D | Vitamin D | Not explicitly detailed in recent reviews | Recent meta-analyses suggest potential for improving cancer treatment outcomes | Not specified | Not specified | 4 | 2 | A toxicity level of 2 for this treatment implies that it has a low toxicity level, meaning the common side effects observed are generally mild and tolerable. The main known side effect is a condition called Hypercalcemia, which is an excessive level of calcium in your blood, that occurs only at high doses of one type of Vitamin D variant. But, it's essential to follow recommended dosage and supplementation strategies for the best therapeutic benefits. The treatment lacks FDA approval currently, hence, it's important to have a conversation with your healthcare provider before starting any new supplement or treatment. |
Loading comments...
Pages in category "Hormones and Cancer Therapy"
The following 5 pages are in this category, out of 5 total.